Phosphodiesterase 5 inhibitor therapy improves clinical parameters in patients with heart failure with preserved ejection fraction and combined post-and pre-capillary pulmonary hypertension

Authors
Category Primary study
JournalCirculation
Year 2017
This article has no abstract
Epistemonikos ID: d3173b5e72a9775b41dfcd2d3f2e8b907f8c571f
First added on: Feb 08, 2025